Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Minocycline FMX-101 Foam in Volunteers
NCT02250859Phase 1Completed
- Sponsor
- Vyne Therapeutics
- Start
- Sep 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of minocycline in acne vulgaris, sponsored by Vyne Therapeutics. Primary endpoints: Adverse Events, Irritation and Local Reaction at 16 days and 5 more. Started Sep 2014; status: completed.
02
Drugs
minocycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02250859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02250859.